Ex vivo confocal laser scanning microscopy for bullous pemphigoid diagnostics: new era in direct immunofluorescence?

Background Ex vivo confocal laser scanning microscopy (ex vivo CLSM) is a novel diagnostic method allowing rapid, high‐resolution imaging of excised skin samples. Furthermore, fluorescent detection is possible using fluorescent‐labelled antibodies. Objective To assess the applicability of ex vivo CL...

Full description

Saved in:
Bibliographic Details
Published inJournal of the European Academy of Dermatology and Venereology Vol. 33; no. 11; pp. 2123 - 2130
Main Authors Bağcı, I.S., Aoki, R., Krammer, S., Ruzicka, T., Sárdy, M., French, L.E., Hartmann, D.
Format Journal Article
LanguageEnglish
Published England Wiley 01.11.2019
Subjects
Online AccessGet full text
ISSN0926-9959
1468-3083
1468-3083
DOI10.1111/jdv.15767

Cover

More Information
Summary:Background Ex vivo confocal laser scanning microscopy (ex vivo CLSM) is a novel diagnostic method allowing rapid, high‐resolution imaging of excised skin samples. Furthermore, fluorescent detection is possible using fluorescent‐labelled antibodies. Objective To assess the applicability of ex vivo CLSM in the detection of basement membrane (BM) fluorescence in bullous pemphigoid (BP) and to compare its diagnostic accuracy with direct immunofluorescence (DIF) microscopy. Methods A total of 81 sections of 49 BP patients with positive DIF microscopy findings were examined using ex vivo CLSM in reflectance and fluorescence mode following staining with fluorescent‐labelled IgG and C3 antibodies. Results Ex vivo CLSM showed an overall performance of 65.3% in identifying BM fluorescence in BP patients. IgG and C3 deposition along the BM was detected in 50% and 45.5% of the patients, respectively. The sensitivity of ex vivo CLSM in detecting BM fluorescence was low (IgG: 50%, C3: 45.5%), but the specificity was high (IgG: 100, C3: 90%). In addition to immunoreactivity, ex vivo CLSM could display subepidermal inflammatory cells similar to histological examination in 84% of patients. Conclusions Basement membrane fluorescence could be identified with ex vivo CLSM in the skin sections of BP patients. Ex vivo CLSM enables simultaneous and rapid detection of histopathological and immunofluorescence findings in the same session, albeit with a lower sensitivity than DIF in detecting BM fluorescence.
Bibliography:Funding sources
Conflict of interest
®
The Prototype Vivascope 2500M‐G4
device was provided by Mavig Ltd. for the time of the study from February to September 2018. All authors declare that they have no financial or personal relationships that could be viewed as a potential conflict of interest.
None declared.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0926-9959
1468-3083
1468-3083
DOI:10.1111/jdv.15767